Table 3

Characteristics of the deceased patients

Patient noCulprit locationCTO locationLVEF at baseline (%)Treatment strategyTime to
CTO-PCI (days)
CTO-PCI successfulTime to death (days)Cause of death
1LADLcX27I6Yes6Definite ST non-CTO lesion (autopsy)
2RCALAD38I4Yes7Found dead/probable ST
3LADLcX45I7Yes8Found dead/probable ST
4LcXRCAI7Yes14Heart failure after definite ST in CTO and culprit
5LADRCA17C20Stroke
6RCALADC143Stroke
7LcXLAD54I3Yes282Stroke
8LcXLAD9C413Pneumonia
9LADRCA17I4No473Heart failure
10LcXRCA28I6Yes597Heart failure
11RCALAD25I3Yes1003Heart failure
12LADRCAI5Yes1029Unexplained death
13RCALAD47C1050Malignancy
14LADRCAC1070Unexplained death
15RCALAD16I7No1112Malignancy
16RCALADI6Yes1139Malignancy
17LADRCAC1209Malignancy
18LADRCA37C1251Stroke
19RCALADI5Yes1345Lung embolic
20LADRCA46I2Yes1435Amyloidosis
21LADRCAI3Yes1775Euthanasia
  • C, conservative strategy (CTO-No PCI); CTO, chronic total occlusion; I, invasive strategy (CTO-PCI); LAD, left anterior descending artery; LcX, left circumflex artery; LVEF, left ventricular function; PCI, percutaneous coronary intervention; RCA, right coronary artery; ST, stent thrombosis.